Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.61
+0.02 (0.05%)
At close: Apr 15, 2026, 4:00 PM EDT
39.05
-0.56 (-1.41%)
After-hours: Apr 15, 2026, 4:40 PM EDT

Centessa Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '20
Cash & Equivalents
61.3383.22128.03393.645
Short-Term Investments
233.2898.96128.52--
Cash & Short-Term Investments
294.58482.18256.55393.645
Cash Growth
-38.91%87.95%-34.83%7768.16%-
Other Receivables
53.9243.7737.8224.17-
Total Trade Receivables
53.9243.7737.8224.17-
Other Current Assets
19.3810.4620.7319.940.01
Total Current Assets
367.88536.41315.09437.755.01
Net Property, Plant & Equipment
10.8511.7612.951.17-
Long-Term Investments
282.55----
Other Long-Term Assets
26.2228.6332.25.390.25
Total Assets
687.5576.8360.25444.315.26
Accounts Payable
7.587.1411.8213.840.02
Accrued Expenses
35.3550.8627.5724.53.46
Short-Term Debt
----4.17
Other Current Liabilities
----0.83
Total Current Liabilities
42.945839.3938.348.48
Long-Term Debt
110.1108.9475.769.8-
Long-Term Leases
7.578.298.89--
Other Long-Term Liabilities
0.030.030.03--
Total Long-Term Liabilities
117.7117.2684.6269.8-
Total Liabilities
160.63175.25124108.148.48
Common Stock
0.410.360.270.270.02
Additional Paid-in Capital
1,7101,386987.42939.26-
Accumulated Other Comprehensive Income
2.714.211.49-1.5-0.09
Retained Earnings
-1,186-988.7-752.95-601.86-3.15
Shareholders' Equity
526.86401.55236.24336.17-3.21
Total Liabilities & Equity
687.5576.8360.25444.315.26
Total Debt
117.67117.2384.5969.84.17
Net Cash (Debt)
176.91364.95171.96323.840.83
Net Cash Growth
-51.52%112.23%-46.90%38823.56%-
Net Cash Per Share
1.303.191.793.470.21
Book Value
526.86401.55236.24336.17-3.21
Book Value Per Share
3.883.512.463.60-0.82
Tangible Book Value
526.86401.55236.24336.17-3.21
Tangible Book Value Per Share
3.883.512.463.60-0.82
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q